Evidence map›Paper›PMID 38138204›Full record

ArticleMedicina (Kaunas, Lithuania)2023

Effects of Anti-COVID-19 Vaccination and Pre-Exposure Prophylaxis with Tixagevimab-Cilgavimab in Kidney and Liver Transplant Recipients.

Roberta Angelico, Francesca Romano, Luigi Coppola, Marco Materazzo, Domiziana Pedini, Maria Sara Santicchia, Roberto Cacciola, Luca Toti, Loredana Sarmati, Giuseppe Tisone

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Roberta AngelicoHPB and Transplant Unit, Department of Surgical Sciences, University of Rome Tor Vergata, 00133 Rome, Italy.ORCID 0000-0002-3439-7750
Francesca RomanoHPB and Transplant Unit, Department of Surgical Sciences, University of Rome Tor Vergata, 00133 Rome, Italy.ORCID 0000-0001-9803-0635
Luigi CoppolaDepartment of System Medicine, Tor Vergata University, 00133 Rome, Italy.ORCID 0009-0005-4728-261X
Marco MaterazzoHPB and Transplant Unit, Department of Surgical Sciences, University of Rome Tor Vergata, 00133 Rome, Italy.ORCID 0000-0002-3599-061X
Domiziana PediniHPB and Transplant Unit, Department of Surgical Sciences, University of Rome Tor Vergata, 00133 Rome, Italy.ORCID 0000-0001-9035-0984
Maria Sara SanticchiaHPB and Transplant Unit, Department of Surgical Sciences, University of Rome Tor Vergata, 00133 Rome, Italy.ORCID 0009-0002-1984-2913
Roberto CacciolaHPB and Transplant Unit, Department of Surgical Sciences, University of Rome Tor Vergata, 00133 Rome, Italy.ORCID 0000-0001-8363-1358
Luca TotiHPB and Transplant Unit, Department of Surgical Sciences, University of Rome Tor Vergata, 00133 Rome, Italy.ORCID 0000-0001-8407-5939
Loredana SarmatiDepartment of System Medicine, Tor Vergata University, 00133 Rome, Italy.
Giuseppe TisoneHPB and Transplant Unit, Department of Surgical Sciences, University of Rome Tor Vergata, 00133 Rome, Italy.
University of Rome Tor Vergata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Liver TransplantationPre-Exposure ProphylaxisAdultAntibodies, MonoclonalAntibodies, ViralCOVID-19 VaccinesHumansKidneySARS-CoV-2VaccinationAntibodies, MonoclonalAntibodies, ViralcilgavimabCOVID-19 Vaccinestixagevimabanti-SARS-CoV-2 antibodies’ titercilgavimabCOVID-19 diseaseimmunosuppressionkidney transplantationliver transplantationlong-active antibodypre-exposure prophylaxisSARS-CoV-2solid organ transplantationtixagevimab

Identifiers

PMID38138204
PMCPMC10744931
OpenAlexW4389175278

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.